Patent details

EP1482924 Title: Cathepsine-cysteïneproteaseremmers.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1482924
WO Application Number:
US2003006147
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP03716238.5
WO Publication Number:
WO2003075836
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Canada (CA)
Publications:

Dates

Filing date:
28/02/2003
Grant date:
21/05/2008
EP Publication Date:
21/05/2008
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/03/2022
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
21/05/2008
EP B1 Publication Date:
21/05/2008
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/02/2023
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
18/09/2018
 
 

 

Name:
Merck Canada Inc.
Address:
16750 Trans-Canada Highway, H9H 4M7, Kirkland, Quebec, Canada (CA)

From:
18/09/2018
 
 

 

Name:
AXYS PHARMACEUTICALS, INC.
Address:
180 Kimball Way, 94080, South San Francisco, California, United States of America (US)

Historical Applicant/holder

From:
21/05/2008
To:
18/09/2018

 

Name:
Merck Frosst Canada Ltd.
Address:
16711 Trans-Canada Highway, H9H 3L1, Kirkland, Québec, Canada (CA)

From:
21/05/2008
To:
18/09/2018

 

Name:
AXYS PHARMACEUTICALS, INC.
Address:
180 Kimball Way, 94080, South San Francisco, California, United States of America (US)

Inventor

1

Name:
Christopher, I. BAYLY
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

2

Name:
Cameron BLACK
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

3

Name:
Serge LEGER
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

4

Name:
Chun Sing LI
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

5

Name:
Dan MCKAY
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

6

Name:
Christophe MELLON
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

7

Name:
Jacques Yves GAUTHIER
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

8

Name:
Cheuk LAU
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

9

Name:
Michel THERIEN
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

10

Name:
Vouy-Linh TRUONG
Address:
H9H 3L1, Kirkland, Québec, Canada (CA)

11

Name:
Michael, J. GREEN
Address:
CA 94080, South San Francisco, United States of America (US)

12

Name:
Bernard, L. HIRSCHBEIN
Address:
CA 94080, South San Francisco, United States of America (US)

13

Name:
James, W. JANC
Address:
CA 94080, South San Francisco, United States of America (US)

14

Name:
James, T. PALMER
Address:
CA 94080, South San Francisco, United States of America (US)

15

Name:
Chitra BASKARAN
Address:
CA 94080, South San Francisco, United States of America (US)

Priority

1

Priority Patent Number:
408704 P
Priority Date:
06/09/2002
Priority Country:
United States of America (US)

2

Priority Patent Number:
361818 P
Priority Date:
05/03/2002
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 31/275;
IPC or IDT classification:
A61P 19/00; C07C 255/25; C07C 255/46; C07C 311/37; C07C 317/32; C07D 209/08; C07D 213/38; C07D 213/64; C07D 213/70; C07D 213/89; C07D 215/12; C07D 231/12; C07D 233/54; C07D 239/26; C07D 241/12; C07D 261/08; C07D 263/32; C07D 271/06; C07D 277/28; C07D 295/12; C07D 307/52; C07D 333/20; C07D 401/04; C07D 417/04;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
40/22
Publication date:
05/10/2022
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
48/18
Publication date:
21/11/2018
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
2008/11
Publication date:
03/11/2008
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
2008/08
Publication date:
01/08/2008
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
200821
Publication date:
21/05/2008
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201801678A
Date Registered:
18/09/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Marks & Clerk (Luxembourg) LLP
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
AXYS PHARMACEUTICALS, INC.
Address:
180 Kimball Way, 94080, South San Francisco, California, United States of America (US)

2

Name:
Merck Canada Inc.
Address:
16750 Trans-Canada Highway, H9H 4M7, Kirkland, Quebec, Canada (CA)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
15/01/2021
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
18/09/2018 Request for Change First filed deed 5 PDF /8/3/2/6/1/0503716238/docs/ep03716238.5_0_rfc20180918015504671.pdf
13/08/2008 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /8/3/2/6/1/0503716238/docs/ep03716238.5_1_incomingcorrespondencepaper20080813.pdf
13/08/2008 Claims Translated claims 29 PDF /8/3/2/6/1/0503716238/docs/ep03716238.5_2_claims20080813.pdf
13/08/2008 Outgoing Correspondence Outgoing Letter 1 PDF /8/3/2/6/1/0503716238/docs/ep03716238.5_3_outgoingcorrespondence20080813.pdf